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This talk will present two views of genome evolution in human breast cancers using fluorescence *in situ* hybridization (FISH) and comparative genomic hybridization (CGH). FISH with chromosome-specific probes applied to thick tissue sections from tumors at several stages of progression reveals a remarkable level of cell-to-cell variability beginning with hyperplasia and increasing with increasing grade. These studies also demonstrate significant genomic evolution, including formation of polyploid nuclei within a single sample, suggesting a very high rate of genomic instability. These phenomena also were observed *in vitro* in few-cell clones established from breast cancer cell lines. Paradoxically, CGH analyses of \'average\' genome copy number changes show relatively slow overall rates of evolution *in vitro and in vivo.* CGH karyotypes for breast cancer cell lines change relatively slowly as long as the environment remains constant. Likewise, CGH karyotypes of pairs of primary vs. metastatic or *in situ* vs. invasive breast tumors from the same patient are usually quite similar, suggesting a relatively slow rate of evolution. Possible explanations for this paradox will be discussed.

Higher resolution analyses of selected regions of recurrent genomic abnormality on chromosome 20, using array CGH and FISH, suggest the coordinate amplification of several genes that play a role in breast cancer evolution. Complete sequencing of a \~ 1 Mb wide region centered on a region of recurrent amplification at 20q13.2 has revealed several genes that appear as possible candidate \'driver\' genes including ZNF217, a gene now implicated in the immortalization of breast epithelial cells.
